<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04089098</url>
  </required_header>
  <id_info>
    <org_study_id>VOLTA-01</org_study_id>
    <nct_id>NCT04089098</nct_id>
  </id_info>
  <brief_title>VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility</brief_title>
  <acronym>VOLTA</acronym>
  <official_title>Characterizing VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility (VOLTA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective observational study will include critically ill patients with hemodynamic&#xD;
      compromise. It will compare passive leg raising and a mini volume challenge (MVC) carried out&#xD;
      on every patient sequentially. The endogenous release of stress hormones will also be assayed&#xD;
      in order to investigate their modifying effect on the hemodynamic reaction of the&#xD;
      participants. The effect of fluid resuscitation on renal perfusion will also be assessed and&#xD;
      the data compared with the release of cystatin C.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fluids are administered either before starting with or during ongoing vasopressor treatment&#xD;
      in critically ill patients with hemodynamic instability. The endogenous release of stress&#xD;
      hormones, namely renin, vasopressin, norepinephrine and cortisol, may be variable in&#xD;
      critically ill patients, which may have a modifying effect on the hemodynamic response.&#xD;
      Passive leg raising (PLR), a validated, simple and dynamic test, is currently recommended for&#xD;
      testing fluid responsiveness. The test might possibly be false negative under extreme&#xD;
      dehydration or increased intra-abdominal pressure. This prospective observational study aims&#xD;
      to compare PLR and MVC with 300 ml Ringer acetate solution administered as a bolus within 5&#xD;
      minutes in critically medical patients with a hemodynamic instability. MVC will be carried&#xD;
      out in every participant following PLR. Blood samples will be collected immediately before&#xD;
      PLR for measurement of renin, copeptin A, cortisol and norepinephrine. These biomarkers will&#xD;
      be compared with the Magnitude of fluid responsiveness. Additionally, renal resistive index&#xD;
      will be assessed with ultrasound immediately before PLR and 1 and 24 hours after fluid&#xD;
      challenge and the data compared with Initial serum cystatin C. Blood samples for measurement&#xD;
      of angiopoietin-2, a marker of capillary leak, will be drawn immediately before PLR and the&#xD;
      data will be correlated with the amount of fluid required for Initial resuscitation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in blood pressure under PLR vs. MVC</measure>
    <time_frame>immediately at the end of the MVC</time_frame>
    <description>changes in mean arterial pressure with PLR vs. MVC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic changes with PLR vs. MVC</measure>
    <time_frame>immediately at the end of the MVC</time_frame>
    <description>Changes in cardiac Output under PLR vs. MVC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluid requirement and endogenous stress response</measure>
    <time_frame>at the end of the first 3 hours of fluid resuscitation</time_frame>
    <description>correlation between fluid requirement and the level of endogenous renin, copeptin A, cortisol and norepinephrine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluid administration versus renal perfusion</measure>
    <time_frame>1 and 24 hours after initial fluid resuscitation</time_frame>
    <description>renal resistive index will be assessed 1 and 24 hours after the Initial fluid resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluid administration and capillary leak</measure>
    <time_frame>at the end of the first 3 hours of fluid resuscitation</time_frame>
    <description>Fluid resuscitation in the first 3 hours vs. initial serum angiopoietin-2</description>
  </secondary_outcome>
  <enrollment type="Actual">125</enrollment>
  <condition>Hemodynamic Instability</condition>
  <condition>Shock</condition>
  <condition>Septic Shock</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>passive leg raising versus mini volume challenge</intervention_name>
    <description>Blood samples will be collected and ultrasound evaluation of renal perfusion conducted in study participants immediately before conducting passive leg raising (PLR). PLR will then be carried out on study participants, followed by MVC. PLR- and/or MVC-responsive patients will receive a further 700 ml fluid immediately after the MVC. Renal perfusion will be further assessed 1 and 24 hours after the MVC.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      norepinephrine renin copeptin A cortisol angiopoietin-2 cystatin C&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill adult medical patients with signs of hemodynamic instability&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  mean arterial pressure &lt;65 mm Hg and/or&#xD;
&#xD;
          -  blood lactate &gt;2 mmol/l and/or&#xD;
&#xD;
          -  mottling or capillary refill &gt;3 seconds and/or&#xD;
&#xD;
          -  oliguria and&#xD;
&#xD;
          -  critical care decision for testing fluid responsiveness&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiopulmonary resuscitation&#xD;
&#xD;
          -  uncontrolled bleeding&#xD;
&#xD;
          -  irreversible brain damage&#xD;
&#xD;
          -  pregnancy and lactation&#xD;
&#xD;
          -  Age under 18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirak Petros, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital of Leipzig, Medical ICU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>D-04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Sirak Petros, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>fluid resuscitation</keyword>
  <keyword>shock</keyword>
  <keyword>volume challenge</keyword>
  <keyword>passive leg raising</keyword>
  <keyword>renal perfusion</keyword>
  <keyword>fluid responsiveness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

